Search for: "United States v. District Court" Results 3021 - 3040 of 34,599
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jun 2012, 12:01 pm by Patent Arcade Staff
Interplay Entertainment Corporation United States District Court, D. [read post]
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
She appealed the district court’s denial of her case to the United States Court of Appeals for the Sixth Circuit. [read post]
15 Sep 2020, 11:02 am by Yolanda J. Bromfield
The United States District Court for the District of Arizona recently addressed the issue of whether the court’s inherent authority can be used to analyze the failure to preserve ESI after amended Rule 37(e) became effective on December 6, 2015. [read post]
15 Sep 2020, 11:02 am by Yolanda J. Bromfield
The United States District Court for the District of Arizona recently addressed the issue of whether the court’s inherent authority can be used to analyze the failure to preserve ESI after amended Rule 37(e) became effective on December 6, 2015. [read post]
15 Sep 2020, 11:02 am by Yolanda J. Bromfield
The United States District Court for the District of Arizona recently addressed the issue of whether the court’s inherent authority can be used to analyze the failure to preserve ESI after amended Rule 37(e) became effective on December 6, 2015. [read post]
25 Mar 2020, 3:00 pm
Six days later, Contec sued CTDI for patent infringement in the United States District Court for the Northern District of New York (“the New York action”). [read post]
5 Sep 2008, 8:28 am
(Apotex) appeals the order of the United States District Court for the District of New Jersey dismissing its declaratory judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. [read post]
On August 29, 2024, the Office for Civil Rights of the United States Department of Health and Human Services (“HHS-OCR”) withdrew its appeal of an order by the United States District Court for the Northern District of Texas’ (“District Court”) declaring unlawful and vacating a portion of an HHS-OCR Bulletin, “Use of Online Tracking Technologies by HIPAA Covered Entities and Business… [read post]
18 Aug 2015, 7:56 am by Law Offices of Jeffrey S. Glassman
Takeda Pharmaceuticals, In the Court of Appeal for the State of California, Second Appellate District, August 13, 2015 More Blog Entries: Report: Testosterone Replacement Injections More Dangerous Than Gels and Patches, June 14, 2015, Boston Testosterone Injury Lawyer Blog The post Cooper v. [read post]